Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, specializing in the development, manufacturing, marketing, and distribution of a broad portfolio of generic and specialty medicines. The company's extensive offerings include generic drugs in various dosage forms such as tablets, capsules, injectables, and transdermal patches, alongside complex sterile products, hormones, and high-potency drugs. Teva also provides active pharmaceutical ingredients and contract manufacturing services, leveraging its robust manufacturing capabilities. A significant portion of Teva's strategic focus is directed towards key therapeutic areas including the central nervous system (CNS), respiratory diseases, and oncology, where it develops both innovative treatments and generic alternatives. The company's branded specialty products address critical unmet needs in these fields, with notable treatments for multiple sclerosis, migraine prevention, movement disorders, and schizophrenia. Teva also maintains a strong presence in over-the-counter (OTC) products under well-recognized brand names. Through strategic collaborations and licensing agreements with other pharmaceutical entities, Teva continually expands its product pipeline and market reach, solidifying its position as a vital contributor to global healthcare accessibility and innovation.